reMYND NV Employee Directory
Biotechnology ResearchFlanders, Belgium11-50 Employees
Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Huntington’s disease. By targeting the underlying disease mechanisms, reMYND aims to restore neuronal function and slow disease progression. With a strong commitment to innovation and patient impact, the company advances breakthrough therapies from discovery to clinical development.